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ttp://dx.doi.org/10.1016/j.ajpath.2013.01.037Arterial endothelial cells maintain vascular homeostasis and vessel tone in part through the secretion of
nitric oxide (NO). In this study, we determined how aortic valve endothelial cells (VEC) regulate aortic
valve interstitial cell (VIC) phenotype and matrix calciﬁcation through NO. Using an anchored in vitro
collagen hydrogel culture system, we demonstrate that three-dimensionally cultured porcine VIC do not
calcify in osteogenic medium unless under mechanical stress. Co-culture with porcine VEC, however,
signiﬁcantly attenuated VIC calciﬁcation through inhibition of myoﬁbroblastic activation, osteogenic
differentiation, and calcium deposition. Incubation with the NO donor DETA-NO inhibited VIC osteo-
genic differentiation and matrix calciﬁcation, whereas incubation with the NO blocker L-NAME
augmented calciﬁcation even in 3D VICeVEC co-culture. Aortic VEC, but not VIC, expressed endothelial
NO synthase (eNOS) in both porcine and human valves, which was reduced in osteogenic medium. eNOS
expression was reduced in calciﬁed human aortic valves in a side-speciﬁc manner. Porcine leaﬂets
exposed to the soluble guanylyl cyclase inhibitor ODQ increased osteocalcin and a-smooth muscle actin
expression. Finally, side-speciﬁc shear stress applied to porcine aortic valve leaﬂet endothelial surfaces
increased cGMP production in VEC. Valve endothelial-derived NO is a natural inhibitor of the early
phases of valve calciﬁcation and therefore may be an important regulator of valve homeostasis and
pathology. (Am J Pathol 2013, 182: 1922e1931; http://dx.doi.org/10.1016/j.ajpath.2013.01.037)Supported by the American Heart Association (grant 0830384N to
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increasingly prevalent clinical problem. CAVD involves the
development and growth of calcium deposits on the surface
and within the ﬂexible leaﬂets of the valve, progressively
occluding the oriﬁce and impairing ventricular function.
Aortic valve stenosis is present in up to 25% of Americans
over the age of 65.1 Even moderate cases of the disease
seriously increase the risks for cardiomyopathy, atheroscle-
rosis, and stroke.2 CAVD is diagnosed hemodynamically via
echocardiography,3 but a clinically useful molecular signa-
ture of CAVD progression remains elusive.4 Recent clinical
trials testing lipid metabolism agents (eg, statins) in CAVD
have been disappointing, but underscore that CAVD patho-
genesis is an active process with distinctly different featuresstigative Pathology.
.from atherosclerosis.5 In particular, large, occlusive miner-
alized lesions develop on the aortic valve cusps, although
vascular calciﬁcations are often signiﬁcantly smaller.6 These
lesions exhibit evidence of both dystrophic calciﬁcation
(calcium crystal nucleation within apoptotic bodies) and
osteogenic calciﬁcation (via osteoblast-like deposition of
Regulation of Valve Calciﬁcationmineralized matrix).7 Valve interstitial cells (VIC) near
calciﬁcations express osteoblast-speciﬁc proteins such
as Runx-2 and osteocalcin, which is replicated in two-
dimensional (2D) cell culture when exposed to osteogenic
differentiation medium (OGM).8,9 Before calciﬁcation, nor-
mally ﬁbroblastic VIC transition to activated myoﬁbroblasts,
exhibiting elevated proliferation and enhanced matrix turn-
over, and expressing contractile proteins such as a-smooth
muscle actin (a-SMA).10e12 The vast majority of studies
investigating the molecular mechanisms of VIC phenotypic
transitions test these cells in artiﬁcial 2D culture conditions
and in isolation from their neighboring endothelium.
Heart valve cusps are lined with endothelium that is criti-
cally important for transducing hemodynamic signals and
delivering nutrients to the underlying VIC. Little is known
about the function of valve endothelial cells (VEC) in tissue
homeostasis and disease pathogenesis. In three dimensional
(3D) co-culture, aortic VEC helpmaintain VIC quiescence by
inhibiting proliferation and myoﬁbroblastic activation in
a shear stressedependent manner.13 Early aortic valve
stenosis is characterized by systemic endothelial dysfunc-
tion.14 In situ gene expression proﬁles show that aortic-sided
VEC normally express fewer inhibitors of calciﬁcation,
directly corresponding to the aortic-sided preference for
calciﬁc nodule formation in CAVD.15 Similarly, VEC
express an anti-calciﬁc gene expression proﬁle when cultured
under unidirectional shear ﬂow,13 but the molecular mecha-
nisms bywhich VEC regulate VIC phenotype remain elusive.
Nitric oxide (NO) is a potent vasodilator secreted primarily
by endothelial cells and confers many cardiovascular beneﬁts
through its action on smooth muscle,16 but its role in aortic
valve function is unclear. Serum levels of endothelial NO
synthase (eNOS) inhibitors correlate with aortic valve
stenosis in patients with CAVD. A large percentage of eNOS-
deﬁcient mice develop bicuspid aortic valves.17 Aortic valve
inﬂammation is associated with decreased NO availability
and increased oxidative stress.18 Increasing NO or intracel-
lular cGMP in 2D cultured VIC inhibits the formation of
calciﬁed nodules.19 Conversely, endothelial NO in diseased
aortic valves can become decoupled from antioxidant
signaling, leading to an increased risk of calciﬁcation.20 These
results suggest that endothelial-derived NO may modulate
VIC calciﬁcation, but to what ends and by what mechanism is
unclear.
The objective of this study was to determine how VEC
modulateVIC fate and tissue homeostasis in calciﬁcation-prone
environments. We establish that VEC naturally suppress VIC
calciﬁcation by reducingmyoﬁbroblastic activation, osteogenic
differentiation, and matrix calciﬁcation of VIC in vitro and
ex vivo. We then determined that endothelial-secreted NO
antagonizes calciﬁcation pathogenesis in aortic valves ex vivo
and in vitro. We additionally show that eNOS-derived NO
signaling through sGC binding and intracellular cGMP activa-
tion is shear stress driven in aortic valves in a side-speciﬁc
manner. Finally, we show that calciﬁed human aortic valves
exhibit reduced eNOS expression in a side-speciﬁc manner.The American Journal of Pathology - ajp.amjpathol.orgMaterials and Methods
Valve Cell Isolation and Culture
Porcine heart valves were kindly donated by Shirk Meats
(Dundee, NY), and Cheal Meats (Essex, UK). Porcine aortic
VEC (PAVEC) and aortic VIC (PAVIC) were isolated using
collagenase digestion as described elsewhere21e23 and cultured
inDulbecco’smodiﬁedEagle’smedium (Invitrogen,Carlsbad,
CA) supplementedwith 10% fetal bovine serum (Gibco,Grand
Island, NY) and 1% penicillin-streptomycin (Gibco) at 37C
and 5% CO2. PAVEC culture medium was further supple-
mented with 50 units/mL heparin (Sigma-Aldrich, St. Louis,
MO). For experiments, PAVIC were used between passages 3
and 8, whereas PAVEC were used between passages 3 and 5.
To conﬁrm the phenotype of cells used in cell cultures,
particularly VEC, a panel of immunoﬂuorescent stains were
conducted (Supplemental Figure S1). Results show positive a-
SMA expression (DRAQ5 nuclear counterstain; BioStatus,
Shepshed, UK) in PAVIC cultures and strong von Willebrand
factor expression (DRAQ5 nuclear counterstain) in PAVEC
cultures, which led us to the conclusion that our isolated
PAVEC are in fact true endothelial EC.
3D in Vitro Valve Calciﬁcation Models
3D collagen hydrogels were created in 3 Dulbecco’s
modiﬁed Eagle’s medium with 10% fetal bovine serum, 2
mg/mL type I collagen, and adequate 0.1 mol/L NaOH to
neutralize the solution (Supplemental Figure S2 and previ-
ously described13,22). Collagen hydrogels were created with
either: i) 1  106 PAVIC cells/mL embedded within the gel
alone; ii) a monolayer of 5  105 PAVEC cells/cm2 seeded
on top of the gel; or iii) combination PAVIC/PAVEC
seeding. Gels were allowed to polymerize for 1 hour in
37C at 5% CO2 before PAVEC monolayer seeding on top
(if applicable). A subset of gels were released after 12 hours
from the bottom of the well plate, allowing them to ﬂoat
freely within the culture medium, whereas the rest remained
geometrically constrained through adhesion to the substrate.
Gels were cultured with either control or osteogenic medium
(control medium supplemented with 10 mmol/L b-glycer-
ophosphate, 50 mg/mL ascorbic acid, and 10 nmol/L dexa-
methasone, OGM) for up to 14 days with media changed
every 48 hours.
Compaction and Calciﬁcation Analysis
Compaction of free-ﬂoating gels (stress-free) under different
experimental conditions was measured from tracings of
digital images and compared as a percentage of the original
area of the gel. To quantify calciﬁed matrix developed in
different experimental conditions, an Alizarin Red absor-
bance assay was implemented. Gels were ﬁxed with para-
formaldehyde and then incubated with 40 nmol/L Alizarin
Red S (ARS) dye. This dye binds to calcium crystals in cells1923
Richards et alor matrix ﬁbers, revealing a red color.24 Unbound solution
was washed out overnight under gentle rocking. Bound ARS
dye was then released from the gels using 10% acetic acid,
followed by neutralization with 10% ammonium hydroxide.
The concentration of dye in solution was then quantiﬁed
using absorbance spectroscopy at 405-nm wavelength.
Quantitative Real-Time RT-PCR
Extraction of total RNA from homogenized hydrogels was
performedusing theRNeasyMiniKit (Qiagen,Valencia, CA),
which was then reverse transcribed into cDNA using the
SuperScript III Reverse Transcriptase kit (Invitrogen),
according to the manufacturer’s instructions. Custom primers
were obtained from Invitrogen and are listed in Table 1. RT-
PCR was performed on all samples using SYBR Green PCR
master mix (Applied Biosystems, Foster City, CA) and
a MiniOpticon Real-Time PCR Detection System (Bio-Rad
Laboratories, Hercules, CA).
Histological and Immunoﬂuorescence Analysis
Collagen gels were ﬁxed overnight in 4% paraformaldehyde
and placed in 70% ethanol. Gels were then parafﬁn embedded
and sectioned at 6 mm. Slides were deparafﬁnized and stained
with H&E (Harleco; EMDMillipore, Billerica, MA) to depict
matrix and cellular architecture. Slides were rinsed and cov-
erslipped with Permount Mounting Medium (Fisher Scien-
tiﬁc, Waltham, MA). Slides were viewed using a Zeiss
microscope (Carl Zeiss, Oberkochen, Germany), and several
representative images were taken from each gel.
For immunoﬂuorescence, gels or coverslips with cells
were ﬁxed in 4% paraformaldehyde, permeabilized with
0.2% Triton-X 100, and blocked with 1% bovine serum
albumin overnight as previously described.22 Gels were
incubated at 4C with 1:100 rabbit anti-human a-SMA or
1:100 rabbiteanti-human von Willebrand factor (Invi-
trogen). Goat anti-rabbit secondary antibody at 1:100 was
incubated for 2 hours at room temperature. The nuclear
counterstain DRAQ5 was incubated for 30 minutes. Speci-
mens were imaged using laser confocal microscopy, and the
images processed using ImageJ software version 1.46r
(NIH, Bethesda, MD) as previously described.22
Additionally, calciﬁed human aortic valves were obtained
from adults undergoing planned, nonelective valve replacementTable 1 Real-Time PCR Primers Used for Porcine Genes in This Study
Gene
Primer
Forward
ACTA2 (aSMA) 50-CAGCCAGGATGTGTGAAG
Osteocalcin (BGLAP) 50-CTCCAGCCACAACATCCT
RUNX2 50-GCACTACCCAGCCACCTT
PECAM 50-ATCTGCATCTCGTGGGAA
NOS1 (nNOS) 50-ATGTCCTCAAAGCCATGG
NOS2 (iNOS) 50-TCCAGGCAATGGAGAGAA
NOS3 (eNOS) 50-CTCCTGCCAGAGAGGATT
1924surgery.Grossly normal, noncalciﬁed humanaortic valveswere
obtained from valve donors from noncardiac deaths. Human
tissue procurement was conducted with the institutional review
boardeapproved protocols at the Hareﬁeld Hospital. Speci-
mens were assessed for eNOS expressing using the above
methods.
Proliferation and Apoptosis Assays
Anti-bromodeoxyuridine (anti-BrdU; Invitrogen) immuno-
histochemistry (IHC) was used to identify proliferating
cells, and a TUNEL assay kit (Invitrogen) was used to
visualize cells undergoing apoptosis. For cell proliferation
analysis, BrdU was added at a 1:100 concentration to the
media for the last 12 hours of the experiment. Gels were
imaged and analyzed in ImageJ. Proliferation was measured
via the percentage of BrdU-positive cells compared to total
cell nuclei, whereas apoptosis was assessed by TUNEL-
positive cells as a percentage of total cell number. Both
proliferation and apoptosis were normalized to control
conditions. DRAQ5 was used as a nuclear counterstain for
proliferation and apoptosis assays.
NO Regulation of Aortic Valve Calciﬁcation in Vitro
PAVIC-only gels were cultured in control and osteogenic
medium as described above, but in the presence of 1 mmol/L
diethylenetriamineNO adduct (DETA-NO; Sigma-Aldrich) as
an NO donor. Fresh DETA-NO was added daily. In the loss-
of-function assay, PAVICþPAVEC gels were treated with
two concentrations (500 mmol/L and 2 mmol/L) of N-nitro-L-
arginine methyl ester (L-NAME; Sigma-Aldrich), which was
added every other day to either control or OGM. Matrix
calciﬁcation and gene expression were quantiﬁed as before.
Ex Vivo Assay for Side-Speciﬁc Aortic Valve
Endothelium Regulation of Leaﬂet Calciﬁcation
We previously published a concentric plate system for
selective exposure of the aortic or ventricular surfaces of
aortic valve cusps in culture.25 Porcine aortic valve leaﬂets
were placed with either ﬁbrosa or ventricularis surface
endothelium exposed to either control or osteogenic medium
conditions for a period of up to 21 days. Calciﬁed lesion loca-
tion, number, and size were determined usingAlizarin Red andReverse
AA-30 50-TCACCCCCTGATGTCTAGGA-30
TT-30 50-TGGCCTCCAGCACTGTTTAT-30
TA-30 50-TATGGAGTGCTGCTGGTCTG-30
GT-30 50-GAGCTGAAGTGTCAGCAGGA-30
AG-30 50-TCTAAGGCGGTTGGTCACTT-30
AC-30 50-CAGGTGGGACAACTTCTGGT-30
TG-30 50-CACCCACATCCCCATCAC-30
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Figure 1 Alizarin Red staining analysis. A: Representative Alizarin Red
S (ARS) stained hydrogels in control (Ctrl), OGM, and co-culture (VICþVEC)
conditions. Scale bar Z 200 mm. B: Quantiﬁcation of calcium deposition
via ARS absorbance in 3D hydrogel VIC/VEC co-culture, n Z 6. Each
measurement is relative to VIC control. Values are expressed as relative dye
absorbance and are means  SEM. *P < 0.05 between treatment groups
(effect of cell type); **P < 0.05 within groups (effect of media).
Regulation of Valve CalciﬁcationvonKossa staining, either en face or in thin sections of parafﬁn-
embedded samples. Number of nodules, nodule size, and
overall distribution were quantitatively compared across
culture medium and exposed leaﬂet surface. Identical ex vivo
leaﬂet culture experiments were conducted in control and
osteogenic medium, but in the presence of 100 mmol/L
L-NAME as a speciﬁc inhibitor of NO synthase. Fresh
L-NAME was added with each medium exchange. Nodule
formation and characteristicswere quantiﬁed as before (nZ 4).
Hemodynamic Regulation of NO Signaling ex Vivo
The ﬁbrosa and ventricular endothelial surfaces of the aortic
valve are exposed to different shear stress patterns in vivo.
Because NO production is regulated by shear stress, we
implemented a previously published cone-and-plate system to
expose either the ﬁbrosa or ventricularis side of the cusps
to their physiological waveforms (12). We used cGMP as
a surrogate for NO production as supported by many stud-
ies.26e28Aortic valve cuspsweremounted in a customhousing
that ensured cusps were oriented perpendicular to the direction
of ﬂow (radially) as in vivo.23,29 The side-speciﬁc VEC were
exposed to their physiological ﬂow patterns and then analyzed
at two time points: 30 minutes or 4 hours. Experiments were
performed in the presence of isobutylmethylxanthine,
a nonspeciﬁc inhibitor of phosphodiesterase, to prevent
degradation of cGMP in the tissue. After experiments, all
tissues were excised, ﬂash frozen, crushed in liquid nitrogen,
and then homogenized in 0.1 mol/L HCl. After centrifugation,
the supernatant was collected and stored at 80C until the
cGMP analysis. cGMP measurements were performed using
a commercially available kit (K372-100; BioVision, Milpitas,
CA). As per the manufacturer’s instructions, the supernatant
was acetylated to increase the sensitivity of cGMP detection,
and the ﬁnished protein G coated plate was read in an optical
spectrometer at 450 nm. Differentiation of cGMP-mediated
effects of NO from cGMP-independent effects was achieved
by selectively exposing leaﬂets to the soluble guanylyl cyclase
inhibitor ODQ and activator BAY in OGM for up to 21 days.
Statistical Analysis
All data are expressed as means  SEM, with at least three
independent experiments per treatment. Data were analyzed
statistically with JMP Pro 10 for Windows software (SAS
Institute,Cary,NC).Analysis ofvariancewithTukey’s post hoc
test was used to compare differences between means (differ-
ences between means were considered signiﬁcant at P 0.05).
Results
VIC calciﬁcation in 3D culture occurs only when mechan-
ically stressed. PAVIC and PAVEC were isolated and phe-
notype conﬁrmed via morphology and IHC (Supplemental
Figure S1). Maintenance of spatial integrity of PAVEC and
PAVIC in 3D cultures over 14 days was conﬁrmed viaThe American Journal of Pathology - ajp.amjpathol.orghistology (Supplemental Figure S3). 3D-cultured PAVIC in
stress-free environments compacted signiﬁcantly more in
OGM than in control medium (5.6%  0.53 versus 8.3% 
0.38 of original area, P < 0.05) over a 7 day period
(Supplemental Figure S4A). Stress-free 3D-cultured PAVIC
did not exhibit any calcium deposition (via ARS staining) in
control or OGM conditions over 14 days (Supplemental
Figure S4B). However, PAVIC cultured within anchored
(mechanically stressed) 3D gels for 14 days developed
signiﬁcant calcium depositionwhen cultured inOGM, but not
in control medium (2.2  0.08 versus 0.88  0.08 relative
ARS dye absorbance, P < 0.05). Interestingly, collagen gels
with PAVEC surfacemonolayers did not compact or have any
detectable calcium deposition, regardless of culture medium.
Mechanically stressed PAVEC-only 3D cultures also did not
calcify, yielding lower relative dye absorbance than VIC
controls (0.13  0.01 in PAVEC control and 0.15  0.03 in
PAVECOGM) (Figure 1). These results suggest that PAVIC,
but not PAVEC, calcify in response to OGM conditions, and
in 3D culture, this process requires mechanical stress.
Valvular endothelial cells inhibit interstitial calciﬁcation in
3D culture. Addition of PAVEC monolayers to 3D-cultured
PAVIC in stress-free, control medium conditions resulted in no
changes in calcium deposition (none detected) or matrix
compaction. In stress-freeOGMconditions, PAVECco-culture
reduced PAVIC matrix compaction (8.0%  0.55% versus1925
Figure 2 IHC and real-time PCR analysis. A:
IHC of a-SMA (green) expression in 3D PAVIC and
PAVICþPAVEC gels. Scale bars: 50 mm. B: Real-
time PCR shows the effect of OGM on the expres-
sion of aSMA (ACTA), osteocalcin (BGLAP), Runx-2
(RUNX2), and eNOS (NOS3) in constrained 3D
PAVIC and PAVICþPAVEC gels (n Z 6). Values are
expressed as fold expression changes and are
means  SEM. *P < 0.05 between treatment
groups (effect of cell type); yP < 0.05 within
groups (effect of media).
Richards et al5.6% 0.33% of original area, respectively,P< 0.05), but still
exhibited no detectable calcium deposition. In mechanically
stressed gels, there was no discernible calcium deposition in
either PAVIC or PAVICþPAVEC co-culture in control
conditions. All measurements are relative to PAVIC control.
Interestingly, PAVEC monolayers co-cultured with PAVIC in
mechanically stressed 3D cultures resulted in signiﬁcantly
reduced matrix calciﬁcation (1.12  0.07 versus 2.24  0.08
AlizarinRedabsorbance in PAVIConly,P< 0.05) (Figure 1,A
and B). These ﬁndings indicate that PAVEC inhibit the PAVIC
calciﬁcation occurring in mechanically stressed 3D culture.
Therefore, the remainder of our studies focused on mechan-
ically stressed 3D culture conditions.
VEC Inhibit Myoﬁbroblastic and Osteoblastic
Differentiation in Vitro
We next examined whether OGM modulated 3D-cultured
PAVIC proliferation or apoptosis via BrdU and TUNEL1926staining, respectively. Proliferation analysis via anti-BrdU
immunostaining revealed no signiﬁcant difference in cell
proliferation due to culture in OGM in any cell type relative to
controls (all P > 0.05) (Supplemental Figure S5A). Addi-
tionally, apoptosis was not signiﬁcantly affected by culture in
OGMover 14 days (allP< 0.05) (Supplemental Figure S5B).
IHC revealed that 3D-cultured PAVIC in OGM increased
a-SMA protein expression relative to controls, which was
reduced with PAVEC co-culture (Figure 2A). Similar results
were found with quantitative real-time PCR, which revealed
a 3.25  0.31-fold increase of aSMA expression in 3D-
cultured PAVIC in OGM compared with controls (P< 0.05).
Co-culture with PAVEC reduced this expression to 0.63 
0.01-fold in OGM, which was in fact less than in control
conditions. PAVEC gels in both control medium and OGM
expressed virtually undetectable aSMA (0.0003  0.0001-
fold in PAVEC control and 0.006  0.006-fold in PAVEC
OGM, P < 0.05) compared to PAVIC controls (Figure 2B).
Stressed 3D cultures of PAVIC exposed to OGM alsoajp.amjpathol.org - The American Journal of Pathology
Figure 3 PAVIC gel analysis. A: Quantitative tissue calciﬁcation via relative absorbance of ARS in constrained 3D PAVIC gels in control and OGM, as well as
OGM treated with 1 mmol/L DETA-NO. Osteocalcin (BGLAP) (B) and Runx-2 (RUNX2) (C) expression in constrained 3D PAVIC gels treated with OGM and 1 mmol/L
DETA-NO. D: Comparison of the effect of different concentrations of L-NAME on the on calcium deposition within co-culture gels via ARS staining. Osteocalcin
(BGLAP) (E) and Runx-2 (RUNX2) (F) expression in constrained 3D co-culture gels treated with OGM and L-NAME. *P < 0.05 between treatment groups (effect
of cell type); yP < 0.05 within groups (effect of media).
Regulation of Valve Calciﬁcationmarkedly up-regulated genes involved in osteogenic differ-
entiation, including osteocalcin (BGLAP) and Runx-2
(RUNX2) (Figure 2B). 3D co-culture of PAVIC with PAVEC
reverted expression of BGLAP and RUNX2 to control levels
(PAVIC BGLAP 3.33  0.44 and RUNX2 5.31  0.57
versus PAVICþPAVEC BGLAP 1.40  0.29 and RUNX2
1.50  0.34 in OGM, P < 0.05) (Figure 3, A and B).
Collectively, these results suggest that calciﬁcation of 3D
PAVIC in this system involvesmyoﬁbroblastic activation and
osteoblastic differentiation, but not apoptosis. Furthermore,
PAVEC mitigates tissue calciﬁcation through inhibition of
PAVIC differentiation.
NO secretion by VEC inhibits osteoblastic differentiation
and matrix calciﬁcation. We conﬁrmed maintenance of
PAVEC monolayers for the full culture period via histology
and PECAM1 gene expression (Supplemental Figures S3 and
S6A). NOS3 (eNOS) gene expression was 24.93  2.48-fold
greater in PAVEC than PAVIC in control medium (P< 0.05)
(Figure 2B). Culture with OGM signiﬁcantly reduced
PAVEC NOS3 expression, but still remained 12.76  3.56-
fold greater than that of PAVIC (P < 0.05). PAVIC-speciﬁc
expression of NOS3 was uniformly low and not affected by
culturemedium.When placed in co-culture withOGM,NOS3
expression remained signiﬁcantly elevated over PAVIC
controls (2.27  0.18-fold, P < 0.05), but markedly reducedThe American Journal of Pathology - ajp.amjpathol.orgin comparison to PAVEC alone (Figure 2B). This was ex-
pected due to the relative amounts of the two cell types in the
co-culture samples. Comparison of NOS3 gene expression
with those of the two other NO synthases, inducible and
neuronal NO synthases [NOS2 (iNOS) and NOS1 (nNOS),
respectively], suggested that PAVEC only express NOS3
whereas PAVIC express NOS2 (Supplemental Figure S6B).
When exogenous NO (1 mmol/L DETA-NO) was adminis-
tered to PAVIC in 3D OGM culture, the same anti-calciﬁc
response as from PAVEC co-culture occurred. DETA-NO
supplementation decreased calcium deposition by PAVIC
by over 30% (2.8  0.3 versus 1.9  0.2 relative absorbance
of Alizarin Red, P < 0.05) (Figure 3A), combined with
similar decreases in osteogenic genes BGLAP and RUNX2
(Figure 3, B and C, respectively). Conversely, when
PAVICþPAVEC co-cultures were treated with 500 mmol/L
and 2 mmol/L NO inhibitor (L-NAME), the anti-calciﬁc
effects of PAVEC were prevented. Calcium deposition
increased twofold in co-culture (Figure 3D) with OGM and L-
NAME, with no effect of concentration. This was combined
with signiﬁcant increases in BGLAP and RUNX2 gene
expression in co-cultures with OGM and L-NAME (Figure 3,
E and F, respectively). As the anti-calciﬁc effects of NO were
onlymimickedwhen PAVECwere added to PAVIC cultures,
we are conﬁdent that the source of NO production in this1927
Figure 4 Alizarin Redepositive nodule analysis. Comparison of Alizarin
Redepositive nodules per high-powered ﬁeld (hpf) formed on the
ventricular and aortic sides of intact valve cusps before (baseline) and after
3 weeks of incubation in control medium (Ctrl), OGM, or OGM supplemented
with 100 mmol/L L-NAME (n Z 4). *P < 0.05 within groups (effect of
media); yP < 0.05 between treatment groups (effect of cell side). Images
within the graph are representative histological sections of ARS-positive
nodules on aortic valve cusps placed in OGM.
Richards et alsystem is endothelial. Therefore, endothelial secreted NO
inhibits osteogenic differentiation and matrix calciﬁcation by
PAVIC.
Calciﬁcation occurs preferentially in the ﬁbrosa of aortic
valves ex vivo. Complementing our in vitro ﬁndings, we
cultured porcine aortic valve leaﬂetswith either the ventricular
or ﬁbrosa surface exposed to OGM or control medium. No
calciﬁed nodule formation was observed in either ﬁbrosa or
ventricularis tissue layers in cusps at fresh (baseline) or after 10
days culture in control medium. Ventricularis-sided culture in
OGM produced a negligible amount of nodules compared to
control medium (0.5  0.5 nodules in OGM versus 0.25 
0.25 nodules in baseline and control, Figure 4). By contrast,
ﬁbrosa-sided culture in OGM developed a signiﬁcant number
of calciﬁc (Alizarin Redepositive) deposits after 10 days
(9.5 3.5 versus 0.5 0.5 nodules/high-powered ﬁeld in the
ventricularis, respectively, P < 0.05). One hundred micro-
molar L-NAME supplemented OGM culture signiﬁcantly
increased the number of calciﬁed lesions in organ culture
compared toOGMalone (15.4 0.8 versus 9.5 3.5 nodules,
P < 0.05). As expected, more calciﬁed lesions formed in the
ﬁbrosa compared to the ventriculariswhenNOwas blocked by
L-NAME (15.4  0.8 versus 5.0  1.4, P < 0.05). Collec-
tively, these results conﬁrm and extend our in vitro ﬁndings by
demonstrating a ﬁbrosa-sided preference for calcium nodule
formation in osteogenic conditions, with calciﬁcation exac-
erbated by inhibition of NO.
Valvular endothelial NO signaling is side speciﬁc and
regulated by ﬂuid shear stress. We previously reported that
eNOS protein expression was greater in the ventricularis than
ﬁbrosa endothelium on healthy porcine aortic valves,13 which
might explain the side-speciﬁc propensity for calciﬁcation.
We therefore investigated the side-speciﬁc nature of eNOS
expression in nondiseased and calciﬁed human aortic valves
(Figure 5A). Almost ﬁvefold more eNOS protein was
expressed on the ventricularis side (2.46 0.50 versus 0.49
0.11, P < 0.05) (Figure 5B) in noncalciﬁed aortic valves.
eNOS expression was signiﬁcantly reduced overall in1928calciﬁed valves compared to nondiseased valves, but
ventricularis-sided endothelial eNOS expression remained
markedly higher than ﬁbrosa-sided expression (2.46  0.50
versus 1.48  0.03 in calciﬁed valves, P < 0.05). Interest-
ingly, the lower basal-level ﬁbrosa-sided eNOS expression
remained statistically unchanged with calciﬁcation (P Z
0.19). Together these results support that eNOS expression is
side speciﬁc and correlates inversely with propensity for
calciﬁcation in aortic valves.
Because eNOS signaling is shear stress sensitive in blood
vessels,30 we hypothesized that hemodynamics may potentiate
side-speciﬁc eNOS signaling.We used cGMP as a quantitative
readout of NO signaling.26e28 En face immunostaining
demonstrated that ventricularis PAVEC had elevated intrinsic
cGMP expression compared to ﬁbrosa PAVEC (Figure 5C).
Ventricular and ﬁbrosa surfaces were then selectively exposed
to their side-speciﬁc physiological ventricular or aortic ﬂow
waveforms in a cone-in-plate apparatus (Supplemental
Figure S7).31 Side-speciﬁc ﬂuid shear stress induced a marked
increase in cGMP production by both endothelial surfaces in
comparison to static controls (2.71 0.26 mmol/L on aortic and
3.75  0.31 mmol/L on ventricular side in ﬂow versus 1.08 
0.25 mmol/L on aortic and 2.09  0.12 mmol/L on ventricular
side in static culture, P < 0.05) (Figure 5D). The pulsatile,
unidirectional, ventricularis ﬂowepatterned shear stress stim-
ulated signiﬁcantlymore cGMPproduction than the oscillatory-
like, ﬁbrosa-sided shear stress patterns (3.75  0.31 mmol/L
versus 2.71  0.26 mmol/L, P < 0.05) (Figure 5D). To deter-
mine whether the increase in cGMP expression was due to NO
signaling, porcine leaﬂets were selectively exposed to the
soluble guanylyl cyclase inhibitor ODQ and activator BAY for
21 days. IHC reveals higher osteocalcin on the ﬁbrosa side in
OGM and OGMþODQ conditions (Figure 5E). a-SMA
expression was higher on both sides of the valve in OGM, with
higher expression on the ventricularis in both OGMþODQ and
OGMþBAY conditions (Figure 5E). Quantiﬁcation of ARS-
positive nodules formed on the leaﬂets in these conditions
revealed a signiﬁcant increase in OGM and OGMþODQ, with
an inhibition of nodule formation with OGMþBAY
(Figure 5F). Taken together, these results indicate that side-
speciﬁc hemodynamic forces regulate local endothelial NO
signaling to modulate the risk of calciﬁcation in aortic valve
leaﬂets.
Discussion
CAVD is a signiﬁcant clinical problem for which basic
pathobiological mechanisms are poorly understood. That
CAVD progression occurs differently than atherosclerosis
was further underscored with the recent disappointing
results of cholesterol metabolism (statin) drug therapy for
aortic valve disease.32 There is, therefore, a signiﬁcant need to
identify functional mechanisms of aortic valve calciﬁcation
and their molecular interactions so as to develop valve-
speciﬁc diagnostic and therapeutic treatments. In this study,
we implemented an anchored 3D hydrogel culture system thatajp.amjpathol.org - The American Journal of Pathology
Figure 5 eNOS expression in human valves. A:
Immunoﬂuorescent staining for eNOS (red) on the
ventricular and aortic sides of normal and calciﬁed
human valves. Arrows indicate eNOS expression.
Scale bars: 20 mm. B: Quantitative measure of eNOS
expression on the ventricular and aortic side of
normal and calciﬁed human valves (measured area of
expression per length). *P< 0.05. C: IHC cGMP (red)
on healthy porcine aortic valves on both ﬁbrosa and
ventricularis sides of the valve cusps. D: Accumula-
tion of cGMP in valve cusps following exposure of the
aortic or ventricular sides of the aortic valve to their
respective patterns of ﬂow. *P < 0.05. E: IHC for
osteocalcin and a-SMA on porcine leaﬂets exposed
to OGM with sGC inhibitor (ODQ) and sGC activator
(BAY). Scale bars: 100 mm. F: Quantiﬁcation of ARS-
positive nodules formed with OGM supplemented
with ODQ and BAY. *P < 0.05
Regulation of Valve Calciﬁcationshowed that mechanical stress was critically important for
developing calcium deposition in a physiological matrix
environment. Theﬁndings of our study identify amultifaceted
mechanism of aortic valve calciﬁc pathogenesis that
integrates microenvironmental hemodynamics, endothelial
function, and interstitial cell differentiation.We identify valve
endothelial-secreted NO as a natural antagonist of multiple
aspects of calciﬁc aortic valve pathogenesis. NO decreases
myoﬁbroblastic activation, osteoblastic differentiation, and
matrix calciﬁcation by valvular interstitial cells. In a comple-
mentary study, we demonstrated that aortic valve endothe-
lium can decrease valve matrix stiffness in an NO-dependent
manner.33 Maintenance of cusp compliance is critically
important for efﬁcient valve function. Substrate stiffness can
alter cellular function34 and was recently shown to potentiate
aortic VIC myoﬁbroblastic differentiation and calciﬁed
aggregate formation in 2D culture with OGM.35 In the native
valve, the ﬁbrosa is stiffer than the ventricularis, which
therefore supports its enhanced risk of calciﬁcation.36,37
Although anchored 3D gels are likely to be mechanically
stiffer than the free-ﬂoating controls,38 our data support
PAVIC calciﬁcation via osteoblastic differentiation rather
than apoptosis in response to OGM, which occurs on
compliant substrates as indicated by Yip et al.35 Therefore,
apoptosis-based calciﬁcation may occur preferentially near
locally rigid, already nucleated calcium deposits rather than
within the initial lesion in aortic valves. Taken together, these
ﬁndings suggest that eNOS mitigates the risk of calciﬁcation
through maintaining a quiescent ﬁbroblastic interstitial cell
phenotype, which may in turn keep mechanical stress at
a healthy basal level.39 It seems, therefore, that disturbance toThe American Journal of Pathology - ajp.amjpathol.orgthis balance, whether via local mechanical, hemodynamic,
and/or eNOS signaling, can cause a vicious cycle of decreased
NO and increased tissue stiffness, both exacerbating the risk
of osteogenic differentiation and matrix calciﬁcation.
Calciﬁed nodules in diseased human aortic valves occur
almost exclusively on the aortic surface.We found in this study
that ﬁbrosa-sided VEC express less eNOS protein and cGMP
than ventricularis-sided VEC, both at baseline and under
physiologicalﬂowconditions.Wehere further conﬁrmed these
eNOS protein expression trends in normal and calciﬁc human
aortic valves. Previous cDNA microarray analyses by Sim-
mons et al15 identiﬁed 20% elevated NOS3 gene expression in
normal pig valves, but no protein or functional analyses of NO
signaling was reported.40 In agreement with the study in
hypercholesteremic rabbits, we found no signiﬁcant difference
in ﬁbrosa sided NOS3 gene expression in calciﬁcation prone
conditions.45 Supporting this NO mechanism, a study by
Kennedy et al19 found thatVIC calciﬁc nodule formation in 2D
culture was blocked by both soluble NO donors or selectively
raising intracellular cGMP concentrations. C-type natriuretic
peptide (CNP), which also stimulates cGMP-dependent
kinases, has also been reported to regulate VIC phenotype
and to have a possible role in regulating the calciﬁcation
process.41 CNP is known to increase cGMP via activation of
a particulate isoformof guanylate cyclase (GC-B),whereasNO
stimulates the soluble isoforms of the enzyme (sGC).42 In our
study, cGMP production and eNOS protein expression were
co-localized speciﬁcally to valve endothelium, stimulated by
side-dependent hemodynamics, and correlated directly with
anti-calciﬁc effects in both pig and human valves. Therefore,
we believe that endothelial NO is the biological entity that1929
Richards et almediates the effects on PAVEC on PAVIC in 3D co-culture,
but further study is warranted to assess the potential of agents
to regulate the valvular interstitial calciﬁcation process that
signal via cGMP-dependent kinases and their potential inter-
actions with NO.
Our results found that ventricularis-sided endothelium was
the main source of NO for the aortic valve, likely due to its
hemodynamic environment. Natural inhibition of ﬁbrosa
calciﬁcation may be maintained via diffusion of NO from the
ventricularis surface, which would be impaired with leaﬂet
thickening and/or ﬁbrosis that precedes calciﬁcation.43
Collectively, these ﬁndings motivate consideration of poten-
tial therapeutic strategies for mitigating or preventing aortic
valve calciﬁcation through targeted valve NO supplementa-
tion, such aswith L-arginine or tetrahydrobiopterin.Our results
also highlight the need for NO-secreting endothelium in
tissue-engineered heart valves.
It is important to note that the beneﬁcial effects of NO in
valves may be more complexly regulated, as Miller et al44
identiﬁed a paradoxical uncoupling of NO in valve tissue
sections that may drive an increase in oxidative stress, which
they localized to calciﬁed valve lesions. Protective NO effects
may therefore be dose dependent. Although our study focused
on eNOS, there are likely other important mechanisms
contributing to valvular calciﬁcation, including side-speciﬁc
heterogeneity. The ﬁbrosa is particularly rich in collagen,
whereas the ventricularis contains a high amount of elastin.
RecentworkbyRodriguez et al45 shows that extracellularmatrix
proteins can independentlymodulate osteoblastic differentiation
of interstitial cells. Indeed, this cross-communication regu-
lates many of the functions of interstitial cells in health and
disease and helps explain the pathophysiology of calciﬁc
vasculopathies in subjects with mutations in collagen or
elastin.46 Recent studies have highlighted the re-emergence
of many genes found in embryonic valve development in
diseased valves, including NOTCH1, POSTN (periostin) and
LECT1 (chondromodulin).47e49
Conclusion
Our results strongly advocate for the incorporation of
endothelial signaling to fully understand the biological and
pathobiological regulation of aortic valve function. This
platform enables direct screening of molecular mechanisms
of calciﬁcation and testing putative molecular inhibitors.
Supplemental Data
Supplemental material for this article can be found at
http://dx.doi.org/10.1016/j.ajpath.2013.01.037.
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